Department of Dermatology, University of Lübeck, Lübeck, Germany.
Lancet. 2013 Jan 26;381(9863):320-32. doi: 10.1016/S0140-6736(12)61140-4. Epub 2012 Dec 11.
Pemphigoid diseases are a group of well defined autoimmune disorders that are characterised by autoantibodies against structural proteins of the dermal-epidermal junction and, clinically, by tense blisters and erosions on skin or mucous membranes close to the skin surface. The most common of these diseases is bullous pemphigoid, which mainly affects older people and the reported incidence of which in Europe has more than doubled in the past decade. Prognosis and treatments vary substantially between the different disorders and, since clinical criteria are usually not sufficient, direct immunofluorescence microscopy of a perilesional biopsy specimen or serological tests are needed for exact diagnosis. In eight pemphigoid diseases the target antigens have been identified molecularly, which has allowed the development of standard diagnostic assays for detection of serum autoantibodies-some of which are commercially available. In this Seminar we discuss the clinical range, diagnostic criteria, diagnostic assay systems, and treatment options for this group of diseases.
天疱疮疾病是一组明确的自身免疫性疾病,其特征是针对皮肤-表皮交界处的结构蛋白产生自身抗体,临床上表现为靠近皮肤表面的皮肤或粘膜上出现紧张性水疱和糜烂。这些疾病中最常见的是大疱性类天疱疮,主要影响老年人,在过去十年中,欧洲的报告发病率增加了一倍多。不同疾病的预后和治疗方法有很大差异,由于临床标准通常不充分,因此需要对病变周围活检标本进行直接免疫荧光显微镜检查或血清学检查以进行准确诊断。在八种天疱疮疾病中,已经从分子水平鉴定出了靶抗原,这使得用于检测血清自身抗体的标准诊断检测方法得以发展,其中一些已经商品化。在本次研讨会上,我们讨论了该组疾病的临床范围、诊断标准、诊断检测系统和治疗选择。